• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Markets

Is it Time to Believe in a Value Rotation?

Questions about the staying power of the present market turn are crucial for portfolio positioning.
By KEVIN CURRAN Jan 26, 2022 | 12:00 PM EST
Stocks quotes in this article: ARKK, TSLA, ZM, COIN, ROKU, BRK.A, BRK.B, XLE, OXY, SLB, JPM, GS, BAC, TFC, MS, BDX, MDT, JNJ

It seems that with each pullback that has hit the market over the past decade, the idea is floated that a real rotation to value from the high-flying growth stocks that have dominated in recent years is imminent.

However, against a backdrop of an accommodative Federal Reserve, a strong economy and low inflation, high-multiple stocks have persisted in pushing higher and leading the market. As these variables augment, there arises a serious question as to whether this time is different.

According to some experts examining the market ahead of an all-important Fed meeting Wednesday, this could very well be the case.

"'This time it's different' are the four worst words in investing. However, we believe this time it definitely is true and things are different," Chuck Etzweiler, Senior Vice President of Research at investment advisory firm Nepsis, told Real Money. "With rising rates and inflationary pressures, we suggest investors shift away from companies with speculative futures and towards those with stability and quality fundamentals that set them apart in this era of restrictive federal policy and inflationary pressures."

Hitting the High-Multiples

Unfortunately for many, this advice was not heeded prior to the start of 2022, leading to quite a bit of pain for growth-focused investors.

For example, growth stock stalwart ETF Ark Innovation (ARKK) is down 27% year to date, while some of its top picks like Tesla (TSLA) , Zoom Video Communications (ZM) , Coinbase (COIN) , and Roku (ROKU) feel similar levels of pain.

"One of the most interesting observations is the comparison of Cathie Wood's ARK Innovation fund to Berkshire Hathaway (BRK.A) (BRK.B) since the start of the coronavirus pandemic," Creighton University professor of Finance Robert Johnson commented. "ARK was outperforming Berkshire by a substantial margin until the recent growth market downturn. It seems to show that you shouldn't count the tortoise out in a race with the hare."

To be sure, many maintain that giving up on growth stocks altogether is not the advisable strategy.

For Gene McManus, Managing Partner at AP Wealth Management, the move is somewhat natural even outside of the looming pressures from the Fed.

"Last year large-cap growth stocks outperformed large-cap value stocks by over 32%," he explained. "Last year's winners are often this year's losers."

McManus added that while investors are likely to be less patient with these stocks given the sentiment shift, there is still promise in many stocks for the future.

"These companies are victims of their own success and financial performance will eventually suffer due to tighter governmental regulations due to policing and data sharing and use," he noted. "Growth stocks' value is in the future."

Positioning Your Portfolio

Nonetheless, in the near term, McManus advised financials, industrials, materials, and energy as the sectors most likely to outperform. He is not at all alone in this projection either.

"Energy stocks will outperform in this rotation," Nathan Rex, Chief Investment Officer at Eigenvector Capital, told Real Money. " I think that the underinvestment in the sector, largely hampered by government regulations limiting drilling, will make energy stocks a reasonable opportunity because of artificial limitations on production expansion."

(Morgan Stanley is a holding in the Action Alerts PLUS member club. Want to be alerted before AAP buys or sells MS? Learn more now.)

Certainly, thus far in 2022, this is a dynamic that has paid out profitably for patient investors in the sector. In contrast to tech stocks taking a hit, the Energy Select Sector SPDR Fund (XLE) has risen about 15% while harder hit components like Occidental Petroleum (OXY) and Schlumberger (SLB) have risen by even greater percentages.

"Financials and energy aren't the totality of value stocks," Rex added as a caveat. "I believe we'll see that industrials are the real value play. Inflationary pressures show there needs to be increased capacity worldwide, and this sector is ripe to deliver real alpha for the foreseeable future as the world scrambles to add that production capacity."

Outside of JPMorgan Chase (JPM) and Goldman Sachs (GS) , each of which was hit by disappointing earnings prints, this has also been evident in the 2022 trajectory of the sector as compared to its S&P benchmark. Among these, Bank of America (BAC) , Truist (TFC) , and Morgan Stanley (MS) have been some of the safest bets despite still-modest returns.

Finally, many investors also see the current market trends tilting towards interest in undervalued healthcare stocks.

"During the pandemic, healthcare has been an ignored sector; it has neither benefited from the pandemic play nor the recovery play," Hank Smith, Head of Investment Strategy at Haverford Trust Company, told Real Money. " The sector is a value play with growth attributes."

As such, Smith sees healthcare as a perfect melding of the aspects that attracted such a high level of inflows to high-flying tech stocks, while offering the downside protection that many of these investors wish they had padded their portfolios with.

"As COVID fades from a pandemic, there will be pent-up demand for doctor visits and elective surgeries," he explained. "Companies like Becton Dickinson and Co (BDX) , Medtronic (MDT) , and Johnson & Johnson (JNJ) should benefit."

In the end, an era of rampant speculation appears to be coming to an inauspicious end. Whether it be in crypto trends, growth stock valuations, or rapidly falling NFT demand, investor appetites are clearly undergoing a swift change.

As such, while growth aspects are going to remain welcome for investors, companies unable to push for profits and sustainable business in line with their growth are likely to remain unfavored, putting investors with large positions in these names in serious peril.

As the market awaits a Fed decision on Wednesday, a modicum of caution via an embrace of value seems a prudent decision.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Curran was long MS, BAC and XLE.

TAGS: Federal Reserve | Indexes | Investing | Markets | Politics | Rates and Bonds | Trading | Value Investing | Energy | Financial Services | Healthcare | Industrials | U.S. Equity

More from Markets

I'm Making Small Bets With These 2 Stocks

Bret Jensen
Jan 27, 2023 11:30 AM EST

While I remain cautious on the overall market, I continue to act upon the limited opportunities I'm finding in the current market.

Adani Companies Plunge Under Hindenburg Attack, Hurting Secondary Sale Attempt

Alex Frew McMillan
Jan 27, 2023 9:30 AM EST

Retail investors may baulk now they are being offered Adani Enterprises shares at a range well above their current trading price.

Rising Above the Resistance

Guy Ortmann
Jan 27, 2023 9:11 AM EST

Five of the indexes rose above their respective near-term resistance levels. Here's what that means for the market.

As the Bears Battle the Bulls, the Market Action Remains Choppy

James "Rev Shark" DePorre
Jan 26, 2023 11:40 AM EST

GDP, unemployment claims, and durable goods reports were better than expected, creating hope that the Fed will be able to create a soft economic landing.

Should You Trade Tesla Now? Here's the Way to Do It

Stephen Guilfoyle
Jan 26, 2023 10:47 AM EST

Elon Musk says he's not worried about any damage done to the Tesla brand due to his activity on Twitter.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • 03:06 PM EST BOB LANG

    LEAPS Webinar

    This week, I offered a free webinar session talkin...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login